Company: INDP
Filing Date: 2025-03-13
Form Type: POS AM
Source: 0001493152-25-010137
Chunk: 30

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: POS AM
Chunk 30
---
 through 
 agents;                                                                                                                                |
| ● | in                                                                                                                                     
 privately negotiated transactions; or                                                                                                  |
| ● | a                                                                                                                                      
 combination of any such methods of sale.                                                                                               |

YA has agreed that, during the term of the Purchase Agreement, neither YA or its affiliates will engage in any short sales or hedging transactions with respect to our shares of common stock, provided that YA and its affiliates may enter into Permitted Sales.

We have advised YA that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this prospectus.

We will pay the expenses incident to the registration under the Securities Act of the offer and sale of our shares of common stock covered by this prospectus by the selling stockholder. We estimate that our total expenses for the offering will be approximately $50,000 (excluding the Commitment Shares). As consideration for its irrevocable commitment to purchase our shares of common stock under the Purchase Agreement, we agreed to issue the Commitment Shares to the selling stockholder, calculated as 1.25% of the Commitment Amount. We also paid a $25,000 structuring fee to an affiliate of the selling stockholder in connection with entry into the Purchase Agreement.

| 19 |

<div align='center'>LEGAL MATTERS</div>

The validity of the common stock being offered by this prospectus has been passed upon for us by Greenberg Traurig LLP.

| 20 |

<div align='center'>EXPERTS</div>

The audited financial statements incorporated by reference in this prospectus and elsewhere in the registration statement have been so incorporated by reference in reliance upon the report of Haskell & White LLP, independent registered public accounting firm, which report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern, and upon the authority of said firm as experts in accounting and auditing.

| 21 |

<div align='center'>incorporation of CERTAIN information by reference</div>

The SEC allows us to incorporate by reference